| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 19387875
[patent_doc_number] => 20240277745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => PEMAFIBRATE AND/OR TOFOGLIFLOZIN FOR USE IN TREATING LIVER DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/564115
[patent_app_country] => US
[patent_app_date] => 2022-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18564115
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/564115 | PEMAFIBRATE AND/OR TOFOGLIFLOZIN FOR USE IN TREATING LIVER DISEASE | May 24, 2022 | Pending |
Array
(
[id] => 19360821
[patent_doc_number] => 20240262855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => A Method For Producing Cationic Saccharides
[patent_app_type] => utility
[patent_app_number] => 18/565781
[patent_app_country] => US
[patent_app_date] => 2022-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18565781
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/565781 | A Method For Producing Cationic Saccharides | May 17, 2022 | Pending |
Array
(
[id] => 19359283
[patent_doc_number] => 20240261317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => METHODS OF TREATING MEDICAL CONDITIONS AND INHIBITING LINE1 REVERSE TRANSCRIPTASEUSING A SUBSTITUTED 4-FLUORO-2,5-DIHYDROFURANYL PHOSPHONIC ACID OR RELATED COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/561644
[patent_app_country] => US
[patent_app_date] => 2022-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -66
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561644
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/561644 | METHODS OF TREATING MEDICAL CONDITIONS AND INHIBITING LINE1 REVERSE TRANSCRIPTASEUSING A SUBSTITUTED 4-FLUORO-2,5-DIHYDROFURANYL PHOSPHONIC ACID OR RELATED COMPOUND | May 16, 2022 | Pending |
Array
(
[id] => 18649534
[patent_doc_number] => 20230295350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => CROSSLINKED DEXTRAN AND CROSSLINKED DEXTRAN-POLY ALPHA-1,3-GLUCAN GRAFT COPOLYMERS
[patent_app_type] => utility
[patent_app_number] => 17/744954
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19918
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744954
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/744954 | CROSSLINKED DEXTRAN AND CROSSLINKED DEXTRAN-POLY ALPHA-1,3-GLUCAN GRAFT COPOLYMERS | May 15, 2022 | Abandoned |
Array
(
[id] => 19389280
[patent_doc_number] => 20240279150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => PROCESS FOR THE MANUFACTURE OF CARBOXYLIC ANHYDRIDE
[patent_app_type] => utility
[patent_app_number] => 18/563005
[patent_app_country] => US
[patent_app_date] => 2022-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4404
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563005
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/563005 | PROCESS FOR THE MANUFACTURE OF CARBOXYLIC ANHYDRIDE | May 10, 2022 | Pending |
Array
(
[id] => 19359281
[patent_doc_number] => 20240261315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => ORAL SOLUTION BASED ON CITICOLINE AND NICOTINAMIDE FOR USE IN THE TREATMENT OF GLAUCOMA
[patent_app_type] => utility
[patent_app_number] => 18/560536
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18560536
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/560536 | ORAL SOLUTION BASED ON CITICOLINE AND NICOTINAMIDE FOR USE IN THE TREATMENT OF GLAUCOMA | May 5, 2022 | Pending |
Array
(
[id] => 19316646
[patent_doc_number] => 20240238186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => Topical Compositions Comprising (Glyco)Sphingolipids and/or (Glyco)Ceramides
[patent_app_type] => utility
[patent_app_number] => 18/557661
[patent_app_country] => US
[patent_app_date] => 2022-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11317
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18557661
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/557661 | Topical Compositions Comprising (Glyco)Sphingolipids and/or (Glyco)Ceramides | Apr 28, 2022 | Pending |
Array
(
[id] => 19528255
[patent_doc_number] => 20240352157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => DISSOLUTION OF CHITOSAN IN APROTIC AQUEOUS MEDIUM COMPOSITION, PREPARATION METHODS AND BIOMEDICAL USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/495033
[patent_app_country] => US
[patent_app_date] => 2022-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18495033
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/495033 | DISSOLUTION OF CHITOSAN IN APROTIC AQUEOUS MEDIUM COMPOSITION, PREPARATION METHODS AND BIOMEDICAL USES THEREOF | Apr 24, 2022 | Pending |
Array
(
[id] => 19280100
[patent_doc_number] => 20240216573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => COMPOSITIONS COMPRISING CROSS-LINKED HYALURONIC ACID AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/286630
[patent_app_country] => US
[patent_app_date] => 2022-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22941
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18286630
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/286630 | COMPOSITIONS COMPRISING CROSS-LINKED HYALURONIC ACID AND METHODS OF USE THEREOF | Apr 12, 2022 | Pending |
Array
(
[id] => 19217804
[patent_doc_number] => 20240182508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => AMPHIPATHIC COMPOUND, PREPARATION METHOD THEREFOR, AND SURFACTANT COMPOSITION COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 18/283016
[patent_app_country] => US
[patent_app_date] => 2022-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18283016
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/283016 | AMPHIPATHIC COMPOUND, PREPARATION METHOD THEREFOR, AND SURFACTANT COMPOSITION COMPRISING SAME | Apr 10, 2022 | Abandoned |
Array
(
[id] => 19263603
[patent_doc_number] => 20240207300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => COMBINATION THERAPIES INCLUDING MYT1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/284614
[patent_app_country] => US
[patent_app_date] => 2022-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52721
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -121
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18284614
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/284614 | COMBINATION THERAPIES INCLUDING MYT1 INHIBITORS | Apr 6, 2022 | Pending |
Array
(
[id] => 19263605
[patent_doc_number] => 20240207302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => ANTIVIRAL COMPOUNDS, METHODS FOR THE MANUFACTURING OF COMPOUNDS, ANTIVIRAL PHARMACEUTICAL COMPOSITION, USE OF THE COMPOUNDS AND METHOD FOR THE ORAL TREATMENT OF CORONAVIRUS INFECTION AND RELATED DISEASES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/553666
[patent_app_country] => US
[patent_app_date] => 2022-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18183
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18553666
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/553666 | ANTIVIRAL COMPOUNDS, METHODS FOR THE MANUFACTURING OF COMPOUNDS, ANTIVIRAL PHARMACEUTICAL COMPOSITION, USE OF THE COMPOUNDS AND METHOD FOR THE ORAL TREATMENT OF CORONAVIRUS INFECTION AND RELATED DISEASES THEREOF | Mar 31, 2022 | Pending |
Array
(
[id] => 19332594
[patent_doc_number] => 20240247024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => INHIBITORS OF NICOTINAMIDE N-METHYL TRANSFERASE (NNMT)
[patent_app_type] => utility
[patent_app_number] => 18/553278
[patent_app_country] => US
[patent_app_date] => 2022-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18553278
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/553278 | INHIBITORS OF NICOTINAMIDE N-METHYL TRANSFERASE (NNMT) | Mar 29, 2022 | Pending |
Array
(
[id] => 19188154
[patent_doc_number] => 20240167067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => Cross-linkable xylans and methods of producing the same and their uses
[patent_app_type] => utility
[patent_app_number] => 18/283472
[patent_app_country] => US
[patent_app_date] => 2022-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18283472
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/283472 | Cross-linkable xylans and methods of producing the same and their uses | Mar 27, 2022 | Pending |
Array
(
[id] => 19187859
[patent_doc_number] => 20240166772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => COMPOSITION COMPRISING CELLULOSE NANOFIBER AND LIGNIN OR COMPLEX OF THESE COMPONENTS, AND METHOD FOR PRODUCING LIGNOCELLULOSE-DERIVED MATERIAL
[patent_app_type] => utility
[patent_app_number] => 18/284318
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18284318
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/284318 | COMPOSITION COMPRISING CELLULOSE NANOFIBER AND LIGNIN OR COMPLEX OF THESE COMPONENTS, AND METHOD FOR PRODUCING LIGNOCELLULOSE-DERIVED MATERIAL | Mar 22, 2022 | Pending |
Array
(
[id] => 19318629
[patent_doc_number] => 20240240172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => Process for Purifying Nucleic Acids, in particular in a Microfluidic Apparatus
[patent_app_type] => utility
[patent_app_number] => 18/562025
[patent_app_country] => US
[patent_app_date] => 2022-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18562025
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/562025 | Process for Purifying Nucleic Acids, in particular in a Microfluidic Apparatus | Mar 21, 2022 | Pending |
Array
(
[id] => 19186237
[patent_doc_number] => 20240165150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => COMBINATION FOR TREATMENT OF THROMBOINFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 18/551936
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11455
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551936
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/551936 | COMBINATION FOR TREATMENT OF THROMBOINFLAMMATION | Mar 20, 2022 | Abandoned |
Array
(
[id] => 19172565
[patent_doc_number] => 20240158539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => FUNCTIONALIZED CELLULOSE, METHOD OF ENZYMATIC FUNCTIONALIZATION OF CELLULOSE, PROCESS OF ENZYMATIC FUNCTIONALIZATION OF CELLULOSE USING AN ORGANIC ACID AND PROCESS FOR THE PRODUCTION OF A CELLULOSE WITH INCREASED HYDROPHOBICITY AND ARTICLE
[patent_app_type] => utility
[patent_app_number] => 18/282453
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7655
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282453
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/282453 | FUNCTIONALIZED CELLULOSE, METHOD OF ENZYMATIC FUNCTIONALIZATION OF CELLULOSE, PROCESS OF ENZYMATIC FUNCTIONALIZATION OF CELLULOSE USING AN ORGANIC ACID AND PROCESS FOR THE PRODUCTION OF A CELLULOSE WITH INCREASED HYDROPHOBICITY AND ARTICLE | Mar 17, 2022 | Abandoned |
Array
(
[id] => 19186235
[patent_doc_number] => 20240165148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => HYALURONIC ACID-CONJUGATED DIPALMITOYL PHOSPHATIDYL ETHANOLAMINE IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) FOR TREATING OR ALLEVIATING INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/549042
[patent_app_country] => US
[patent_app_date] => 2022-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5645
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549042
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/549042 | HYALURONIC ACID-CONJUGATED DIPALMITOYL PHOSPHATIDYL ETHANOLAMINE IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) FOR TREATING OR ALLEVIATING INFLAMMATORY DISEASES | Mar 12, 2022 | Pending |
Array
(
[id] => 19050853
[patent_doc_number] => 20240092822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => PURIFICATION METHODS FOR OLIGOMERIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/548711
[patent_app_country] => US
[patent_app_date] => 2022-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15517
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -53
[patent_words_short_claim] => 234
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548711
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/548711 | PURIFICATION METHODS FOR OLIGOMERIC COMPOUNDS | Mar 1, 2022 | Pending |